Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Molecular Therapeutics
100%
FLT PET
100%
PET Imaging
100%
Tumor
80%
Cytostatic Agents
80%
Nucleoside Transporters
40%
Kinase Activity
40%
Tumor Proliferation
40%
Signal Transduction Pathway
40%
Cytostatic
40%
Nucleoside Kinase
40%
Novel Therapeutics
40%
Common Mechanisms
20%
Mechanism of Action
20%
Functional Response
20%
Patient-specific Treatment
20%
Transporter Activity
20%
Appropriate Therapy
20%
Genotyping Assays
20%
Cell Cycle Progression
20%
Metabolism
20%
Biochemical Assay
20%
Genetic Predictors
20%
Cell Cycle Arrest
20%
Tumor Response
20%
Non-responders
20%
Molecular Targeted Agents
20%
Therapeutic Agents
20%
U87 Glioma Cells
20%
Inhibit Tumor
20%
Cellular Accumulation
20%
PET Ligands
20%
Tumor Cell Lines
20%
Biochemical Predictors
20%
Functional Imaging
20%
Specific Ligand
20%
Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor (EGFR-TKI)
20%
Surrogate Assay
20%
G1 Arrest
20%
Tumor Regression
20%
Anatomic Imaging
20%
18F-fluorocholine PET/CT
20%
Tissue Culture
20%
Fluorodeoxyglucose Uptake
20%
Fluorodeoxyglucose
20%
Pharmacology, Toxicology and Pharmaceutical Science
Polyethylene Terephthalate
100%
Cytostatic Agent
66%
Fluorodeoxyglucose
50%
Nucleoside
33%
Tumor Growth
33%
Phosphotransferase
33%
Neoplasm
33%
Cytostatic
33%
Tumor Regression
16%
Nucleoside Transporter
16%
Glioma
16%
Epidermal Growth Factor Receptor Kinase Inhibitor
16%